Biotechnology

With this R&D center, the Galicia-based company expects to increase its turnover by 25% over the next two years and step up its growth and internationalisation plan.

 

GalChimia was established in 2001 as a spin-off at the University of Santiago de Compostela in a business venture run by organic chemistry PhDs Carme Pampín and Jacobo Cruces.

 

Its funding comes from its operations and all its share capital is still owned by the entrepreneurial team of Drs Pampín and Cruces, USC Organic Chemistry Department lecturers Gabriel Tojo and Ramón Estévez, and venture capital firm Unirisco Galicia.

 

The EU will support 257 small and medium-sized companies (SMEs) from 31 countries who aim to get their innovations faster to the market. The companies have been selected in the latest round of the SME Instrument, which is part of the recently launched European Innovation Council (EIC) pilot. The funding of €12.65 million in total comes from Horizon 2020, the EU research and innovation programme.